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Epigenetic mechanisms regulating lineage differenti-
ation of mammary stem cells (MaSCs) remain poorly
understood. Pygopus 2 (Pygo2) is a histone methyl-
ation reader and a context-dependentWnt/b-catenin
coactivator. Here we provide evidence for Pygo2’s
function in suppressing luminal/alveolar differentia-
tion of MaSC-enriched basal cells. We show that
Pygo2-deficient MaSC/basal cells exhibit partial
molecular resemblance to luminal cells, such as
elevated Notch signaling and reduced mammary
repopulating capability upon transplantation. Inhibi-
tion of Notch signaling suppresses basal-level and
Pygo2-deficiency-induced luminal/alveolar differen-
tiation of MaSC/basal cells, whereas activation of
Wnt/b-catenin signaling suppresses luminal/alveolar
differentiation and Notch3 expression in a Pygo2-
dependent manner. We show that Notch3 is a direct
target of Pygo2 and that Pygo2 is required for
b-catenin binding and maintenance of a poised/
repressed chromatin state at the Notch3 locus in
MaSC/basal cells. Together, our data support
a model where Pygo2-mediated chromatin regula-
tion connects Wnt signaling and Notch signaling
to restrict the luminal/alveolar differentiation com-
petence of MaSC/basal cells.
INTRODUCTION
Adult stem cells play important roles in tissue homeostasis and
regeneration and serve as cells of origin of some human cancers
(Visvader, 2011). Thus, understanding how their lineage differen-
tiation is governed by the interplay between intracellular epige-
netic machinery and extracellular signaling will not only provide
mechanistic guidance for tissue engineering but also help pre-
dict the behavior of heterogeneous tumors. The mouse mam-
mary gland is an excellent model to study adult stem cells
because it is a dynamic ductal epithelial organ that develops/ex-
pands during puberty/pregnancy and regresses to a virgin-like
state after lactation (Gjorevski and Nelson, 2011). Mounting evi-
dence argues for a hierarchical organization within themammary
epithelia, leading to a prevailing model that multipotent mam-48 Cell Stem Cell 13, 48–61, July 3, 2013 ª2013 Elsevier Inc.mary stem cells (MaSCs) residing within the basal compartment
give rise to all lineage-restricted progenitor cells and their mature
progenies (Visvader, 2009). Supporting this model, specific sub-
populations of mammary epithelial cells (e.g., MaSC-enriched
basal cells [MaSC/basal] marked by LinCD29highCD24+ surface
marker expression) are able to generate an entire mammary tree
that comprises all lineages—the inner layer of ductal and alveolar
luminal cells, and the outer layer of basal/myoepithelial cells—
upon transplantation into epithelia-cleared fat pads of host
mice (Shackleton et al., 2006; Stingl et al., 2006). However, there
also exists theoretic and experimental evidence for bidirectional
conversion between stem and differentiated mammary epithelial
cells (Chaffer et al., 2011; Guo et al., 2012; Gupta et al., 2011).
Moreover, recent findings from lineage tracing experiments
demonstrate that lineage-restricted basal and luminal progenitor
cells drive mammary morphogenesis during postnatal develop-
ment and pregnancy (van Amerongen et al., 2012; Van
Keymeulen et al., 2011). While epigenetic mechanisms likely
dictate the restricted lineage progression of MaSC/basal cells
under physiological conditions and their impressive plasticity
upon transplantation, the actual players that regulate mammary
lineage potential remain uncharacterized. Insights into this issue
promise to uncover epigenetic principles of lineage differentia-
tion of epithelial stem cells and shed light on the basis of breast
cancer heterogeneity.
Central to the ‘‘histone code’’ hypothesis, the complex pat-
terns of histone modifications, such as methylation and acetyla-
tion, are recognized and interpreted (‘‘read’’) by effector proteins
that in turn bring about changes to the chromatin structure that
activate or repress transcription (Jenuwein and Allis, 2001).
The Pygopus family of highly conserved plant homeo domain
(PHD)-containing proteins was initially discovered as transcrip-
tional coactivators of the Wnt/b-catenin signaling pathway
(Belenkaya et al., 2002; Jessen et al., 2008; Kramps et al.,
2002; Parker et al., 2002; Thompson et al., 2002). Subsequent
studies revealed that these proteins possess the ability to
directly bind histone H3 that is trimethylated at lysine 4
(H3K4me3, a histone mark associated with active transcription)
and thus act as histone methylation readers (Fiedler et al.,
2008; Gu et al., 2009; Kessler et al., 2009).Moreover, mammalian
Pygopus 2 (Pygo2) participates in ‘‘writing’’ of the histone code
by interacting with and recruiting histone-modifying enzymes
to target chromatin to facilitate the production of additional
active histone marks such as H3K4me3 (Andrews et al., 2009;
Chen et al., 2010; Gu et al., 2009; Gu et al., 2012; Nair et al.,
2008). Germline deletion of Pygo2 results in defective embryonic
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knockout (SSKO) ofPygo2 leads to a transient delay inmammary
ductal morphogenesis during puberty (Gu et al., 2009). Whether
and how this chromatin effector regulates the lineage potential of
adult MaSC/basal cells remain to be addressed.
Wnt/b-catenin and Notch signaling are two fundamental path-
ways that regulate stem cells in myriad tissues (Reya and
Clevers, 2005; Takebe et al., 2011). In mammary epithelia,
Wnt/b-catenin signaling is active in, and promotes the self-
renewal of, MaSCs, and its ectopic activation within the MaSC/
basal compartment leads to accumulation of basal cells (Roarty
and Rosen, 2010; Teulie`re et al., 2005; van Amerongen et al.,
2012; Zeng and Nusse, 2010). In contrast, Notch signaling re-
stricts MaSC/basal self-renewal and promotes their commit-
ment/differentiation to a luminal fate (Bouras et al., 2008; Buono
et al., 2006; Raouf et al., 2008). Deregulation of both pathways
leads to mammary tumorigenesis, with Wnt signaling targeting
MaSCs and Notch signaling targeting the luminal cell types
(Visvader, 2011). The molecular relationship between these
pathways in controlling the decision between self-renewal and
differentiation as well as the balance between basal and luminal
lineages remains unknown.
In this study, we investigate the involvement of Pygo2 in mam-
mary lineage differentiation. We find Pygo2 to maintain an
MaSC/basal fate by suppressing their luminal/alveolar differenti-
ation and show that this occurs at least in part via suppression of
Notch signaling. Our data highlight Pygo2 as an epigenetic regu-
lator that directly links the self-renewal-promoting Wnt pathway
to the luminal-promoting Notch pathway. Finally, we show that
Pygo2 acts in MaSC/basal cells to facilitate b-catenin binding
to the Notch3 locus and to maintain Notch3 in a ‘‘bivalent’’ chro-
matin structure (Bernstein et al., 2006; Wei et al., 2009).
RESULTS
Reduced Presence of MaSC/Basal and Luminal
Progenitor Cells in Pygo2-Deficient Mammary Epithelia
Consistent with our previous finding (Gu et al., 2009), fluores-
cence activated cell sorting (FACS) analysis revealed a reduced
number of MaSC-enriched LinCD29highCD24+ basal/myoepi-
thelial (MaSC/basal) cells relative to the total Lin population in
adult Pygo2 SSKO mammary epithelia (Figure 1A). The overall
size of the bulk luminal population (LinCD29lowCD24+) varied
from mouse to mouse, but the relative presence of the CD61+
luminal/alveolar progenitor cell pool (Asselin-Labat et al., 2007)
within this population was consistently and significantly lower
in SSKO glands than in the controls (Figure 1A). Furthermore,
we observed a significant reduction in the relative size of the
LinCD24lowCD49flow population previously shown to encom-
passmature basal/myoepithelial cells (MYO), whereas the differ-
ence in the size of the LinCD24highCD49flow population, known
to contain mammary colony-forming cells (Ma-CFCs) (Stingl
et al., 2006), between control and SSKO was insignificant (Fig-
ure 1B). Together, our results demonstrate that Pygo2 loss asso-
ciates with smaller pools of both bulk basal/myoepithelial cells
and luminal/alveolar progenitor cells relative to the mature
luminal population.
To determine whether there is any lineage imbalance in
Pygo2-deficient mammary epithelia, we stained control andSSKOmammary ducts using keratin 19 (K19), a luminal-enriched
protein, and smooth muscle actin (SMA), a basal/myoepithelial
marker (Bartek et al., 1985; Gugliotta et al., 1988; Sun et al.,
2010). Quantification of K19+ and SMA+ cells revealed a statisti-
cally significant increase in the ratio between luminal and basal/
myoepithelial cells in ductal sections from SSKO mice (p < 0.05;
Figure 1C).
Pygo2 Suppresses Luminal/Alveolar Differentiation of
Sorted MaSC/Basal Cells
We next asked whether MaSC/basal cells were reduced in the
absence of Pygo2 as a consequence of direct, precocious differ-
entiation toward a luminal state. MaSC/basal cells isolated from
control and Pygo2 SSKO glands were compared for their differ-
entiation potential using a 3D Matrigel assay (Shackleton et al.,
2006) (Figure 2A). Two major, morphologically distinct types of
colonies were observed in the control culture: branched and
acinar-like (Figures 2A and 2B), which were likely derived from
MaSC/basal progenitor and luminal/alveolar-restricted progeni-
tor cells, respectively (Dontu et al., 2003; Petersen et al., 1992;
Shackleton et al., 2006). As expected (Shackleton et al., 2006),
both types of colonies expressed basal marker Keratin 14
(K14) and luminal marker K8 (Figure 2B). Interestingly, the ratio
between acinar and branched colonies was significantly higher
in SSKO than in the control culture (Figure 2C). Consistently,
the mRNA levels of Muc1, Csn2 (b-casein), and Stat5a, but not
of Krt19 (K19, were also significantly upregulated in the SSKO
culture (Figure 2D). Therefore, it appears that Pygo2-deficient
MaSC/basal cells are prone to adopt a luminal/alveolar fate
and/or undergo luminal/alveolar differentiation ex vivo.
To address the immediate effect of Pygo2 loss onMaSC/basal
differentiation, we performed a 3D Matrigel assay on sorted
MaSC/basal cells from Pygo2flox/flox and Pygo2flox/+ mice
following their infection with adenoviruses expressing Cre-
IRES-GFP (Ade-Cre) (Figure S1A available online). Efficient dele-
tion of Pygo2 was verified by recombination at the floxed Pygo2
locus (Figure 2E), the significant reduction of Pygo2 mRNA in
Pygo2flox/flox comparing to Pygo2flox/+ cells (Figure 2F), and the
loss of Pygo2 protein in GFP+ Pygo2flox/flox cells (Figure S1B).
Acute depletion of Pygo2 led to a significant increase in the ratio
between acinar and branched colonies (Figure 2G), indicating
that Pygo2 plays a direct role in promoting the luminal/alveolar
differentiation of MaSC/basal cells.
Pygo2-Deficient MaSC/Basal Cells Exhibit a Partial
Transcriptional Drift toward aMature Luminal State and
Reduced Repopulating Ability upon Transplantation
Next we tested the hypothesis that Pygo2 suppresses luminal/
alveolar differentiation of MaSC/basal cells by earmarking their
differentiation competence. First, we found Pygo2 mRNA to
be present (in decreasing abundance) in MaSC/basal
(LinCD29highCD24+), luminal progenitor (LinCD29lowCD24+
CD61+), and mature luminal cells (LinCD29lowCD24+CD61)
(Figures S2A and S2B). Next, we asked whether Pygo2-deficient
MaSC/basal cells differ molecularly from their control counter-
parts despite the fact that they are identified by the same surface
markers. Interestingly, MaSC/basal-specific genes Acta2 (SMA)
and p63 showed a trend of reduced expression in Pygo2-defi-
cient MaSC/basal cells compared to the control, whereas K19,Cell Stem Cell 13, 48–61, July 3, 2013 ª2013 Elsevier Inc. 49
Figure 1. Loss of Pygo2 Results in Reduced Numbers of MaSC/Basal and Luminal Progenitor Cells
(A and B) FACS analysis of mammary glands of 8- to 12-week-old virgin control and Pygo2 SSKOmice using the Lin/CD29/CD24/CD61 (A) or Lin/CD24/CD49f (B)
surface marker set. Left, representative FACS profiles. Right, quantitative results. MRU, mammary repopulating unit.
(C) Immunofluorescence analysis of K19+ luminal or SMA+ basal cells in mammary ducts from 4- to 8-week-old control and SSKOmice. n > 4 per genotype used
for all quantifications. Values are means ± standard deviations (SD); *p < 0.05; **p < 0.01. Bar = 25 mm.
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basal to luminal cells, was slightly elevated in Pygo2-deficient
MaSC/basal and luminal progenitor cells (Figure S2B). To eval-
uate comprehensively whether Pygo2-deleted MaSC/basal cells
exhibit luminal-like molecular features, we performed DNA mi-
croarray analysis to compare gene expression in three sorted50 Cell Stem Cell 13, 48–61, July 3, 2013 ª2013 Elsevier Inc.populations: control MaSC/basal, Pygo2 SSKO MaSC/basal,
and control mature luminal cells (Figure 3A). List 1 (9,308 genes)
included genes whose expression was significantly changed
from control MaSC/basal to control luminal cells (Figure 3B).
List 2 (798 genes) included genes whose expression is consis-
tently changed in MaSC/basal cells due to Pygo2 deficiency
Figure 2. Pygo2 Loss Facilitates Luminal/Alveolar Differentiation of MaSC/Basal Cells in 3D Matrigel Culture
(A) Experimental procedure.
(B) Examples of branched (b) and acinar-like (a) colonies produced after differentiation induction with HIP (see Experimental Procedures for details). Patterns of
K8 (red) and K14 (green) expression as analyzed by confocal microscopy are shown in 3D reconstructed (left) and single-plane (right) images. Arrowheads
indicate a few K14+ basal cells bordering an acinar colony.
(C) Morphology (left) and quantification (right) of colonies produced by control and SSKO (n = 3 each) MaSC/basal cells, 6 (left), 4 (right), and 8 (right) days after
differentiation induction.
(D) RT-qPCR analysis of expression of the indicated genes in control and SSKO (n = 3 each) colonies produced 6 days after HIP induction.
(E) Genotyping analysis of uninfected or Ade-Cre-infected Pygo2flox/+ and Pygo2flox/flox MaSC/basal cells.
(F) RT-qPCR analysis of Pygo2 expression in cells 3 days after infection.
(G) Effect of acute Pygo2 deletion on colony formation. Shown are results of quantitative analysis of Ade-Cre-infected MaSC/basal cells from four pairs of
Pygo2flox/+ and Pygo2flox/flox mice. Values are means ± SD; *p < 0.05; **p < 0.01.
Bar = 50 mm in (B) and 300 mm in (C). See also Figure S1.
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Figure 3. Transcriptional Profiling of Control and Pygo2 SSKO Mammary Populations
(A) Schematic diagram outlining the strategy to identify coregulated genes.
(B) Venn diagram illustrating the overlap between lists 1 (p < 0.05) and 2 (p < 0.05).
(C) Heat map of the coregulated genes.
(D) GSEA indicates enhanced luminal and diminished basal gene signatures in Pygo2 SSKO MaSC/basal cells.
(legend continued on next page)
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Pygo2 in Breast Stem Cell Differentiation(Figure 3B). A comparison of the two lists revealed that 43% of
the Pygo2-sensitive genes were part of the luminal gene signa-
ture (termed ‘‘coregulated;’’ Figure S2C). Interestingly, coregula-
tion became more prominent when higher stringency cut-offs
were applied. Coregulated genes included known luminal
markers/regulators, such as K19, amphiregulin (Areg), and fork-
head box protein A1 (Foxa1), the upregulation of which in
SSKOMaSC/basal cells was confirmed by reverse-transcription
quantitative PCR (RT-qPCR) (Figures 3C and S2D–S2F). Overall,
our molecular analysis paints a scenario wherein the expression
of a subset of genes in Pygo2-deficient MaSC/basal cells is of
intermediate levels between normal MaSC/basal and luminal
states.
Gene Set Enrichment Analysis (GSEA) (Subramanian et al.,
2005) confirmed that, compared to control MaSC/basal cells,
Pygo2-deleted MaSC/basal cells exhibited a significant upregu-
lation of several published mammary luminal gene signatures
(Gupta et al., 2011; Huper andMarks, 2007; Lim et al., 2010) (Fig-
ure 3D, Table S1). In contrast, GSEA indicated a specific down-
regulation of basal gene signatures in SSKO MaSC/basal cells.
Furthermore, compared to control MaSC/basal cells, SSKO
MaSC/basal and control mature luminal cells displayed similar
alterations in the expression of several gene ontology (GO)
groups, including decreased expression of G1-S cell cycle
genes (Gu et al., 2009) and increased expression of cell adhesion
genes (Figure 3E). Taken together, our results are consistent with
a partial drift of gene expression in Pygo2-deficient MaSC/basal
cells toward a mature luminal state.
To determine the significance of this molecular drift, we
performed limiting dilution transplantation assays using
LinCD29highCD24+ MaSC/basal cells isolated from control
and Pygo2 SSKO mammary glands. Compared to the control,
SSKO MaSC/basal cells displayed a significantly reduced rate
of successful transplantation and less extensive mammary
outgrowth (Figure 3F). We estimated that Pygo2 loss led to a
5-fold reduction in repopulating frequency. Therefore, Pygo2-
deficient MaSC/basal cells are compromised in their ability to re-
populate the epithelia-cleared mammary fat pad.
Pygo2 Suppresses Notch Signaling in MaSC/Basal Cells
Among the genes upregulated in Pygo2-deficient MaSC/basal
cells were several Notch signaling components, including
Notch3, Dll4, and Hes1 (Figure S3A). RT-qPCR analysis using
independently sorted cell populations confirmed higher expres-
sion of Notch3 and Hes1 in SSKO MaSC/basal and luminal pro-
genitor cells compared to the control counterparts (Figure 4A).
The expression of Notch1, Notch2, Notch4, and Hey1 was also
upregulated in SSKOMaSC/basal cells, but not in SSKO luminal
progenitor cells (Figure 4A). Moreover,Notch3 andHes1, but not
Notch1, Notch2, Notch4, and Hey1, showed higher expression
in control mature luminal cells than in control MaSC/basal cells,
opposite of that of Pygo2 (Figures 4A, S2B, and S3A). These re-
sults demonstrate elevated Notch pathway activity in Pygo2-(E) Top-ranked gene sets in GO analysis.
(F) Summary of limiting dilution transplantation results. Top panel shows the repre
and Pygo2 SSKO MaSC/basal cells. Bar = 1 mm. Bottom table summarizes the
resents one transplanted fat pad, and the percentage of darkness in the circle in
See also Figure S2 and Table S1.deficient MaSC/basal cells and identify a tight inverse correlation
between Notch3 and Pygo2 expression. Supporting a cell-
autonomous, repressive effect of Pygo2 on Notch3, overexpres-
sion and depletion (using two different shRNAs) of Pygo2 in
MCF10A mammary epithelial cells resulted in reduced and
elevated, respectively, levels of Notch3 mRNA, whereas no ef-
fect was seen for Notch1 and Notch2 (Figure S3B).
To ask whether Notch3 upregulation occurred in the entire
SSKO MaSC/basal population or only a subset of the cells, we
performed FACS analysis on mammary cells harvested from
control and SSKO mice using Notch3 antibody together with
the Lin/CD29/CD24 marker set. Whereas the control MaSC/
basal population contained two subpopulations of cells that
can be described as Notch3low and Notch3medium, the Pygo2-
deficient MaSC/basal population contained a more abundant
Notch3medium subpopulation and a distinct Notch3high subpopu-
lation (Figure 4B, left). Quantification of Notch3high cells revealed
a significant increase in SSKO samples (Figure 4B, right). These
data provide in vivo evidence that in the absence of Pygo2, both
Notch3low and Notch3medium cells within the MaSC/basal popu-
lation gain higher Notch3 protein expression.
To determine the functional relevance of increased Notch
signaling in Pygo2-deficient MaSC/basal cells, we first
treated these cells in 3D Matrigel culture with N-[(3,5-difluoro-
phenyl)acetyl]-L-alanyl-2-phenylglycine-1,1-dimethylethyl ester
(DAPT), a g-secretase inhibitor that blocks the activating, pro-
teolytic cleavage of Notch receptors (Geling et al., 2002). As ex-
pected (Bouras et al., 2008), DAPT reduced the expression of
targets of Notch signaling (Figure S3C) and suppressed the for-
mation of acinar colonies in the control MaSC/basal culture (Fig-
ure 4C). Importantly, DAPT also completely suppressed the
greatly enhanced acinar colony formation in the Pygo2-deficient
MaSC/basal culture, regardless of whether deficiency was engi-
neered chronically or acutely (Figure 4C). This cellular phenotype
correlated well with a significant suppression of luminal/milk
genes K19, Muc1, b-casein, and Stat5a (Figure 4D).
We next depleted Cbf1, a transcription factor essential for
Notch signaling, in control and Pygo2 SSKO MaSC/basal cells
by infecting them with lentiviruses expressing Cbf1-specific
shRNA and GFP (Bouras et al., 2008) (Figure S3D). Compared
to treatment with control viruses expressing a scramble shRNA
and GFP, and similar to DAPT treatment, Cbf1 knockdown led
to a significant decrease of both basal-level and Pygo2-defi-
ciency-induced formation of acinar colonies in 3D Matrigel
culture (Figures 4E and S3E). Upon transplantation, Cbf1-
depleted control MaSC/basal cells produced mammary out-
growths with increased but disorganized branching and
aberrant terminal buds (Figure 4F), defects attributed to Notch
signaling’s restrictive role of an MaSC/basal state (Bouras
et al., 2008). Importantly, albeit smaller, the transplants gener-
ated by Pygo2 SSKO MaSC/basal cells also showed elevated
branching frequency and aberrant terminal buds upon Cbf1
knockdown (Figure 4F). Taken together, these results showsentative whole-mount analysis of mammary glands regenerated from control
transplantation results from three independent experiments. Each circle rep-
dicates the proportion of the fat pad that is filled by the transplant.
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elevated luminal/alveolar differentiation in Pygo2 SSKO MaSC/
basal cells.
Activation of Wnt/b-Catenin Signaling Suppresses
Luminal/Alveolar Differentiation and Notch Signaling
in a Pygo2-Dependent Manner
Given the context-dependent role of Pygo2 as aWnt coactivator,
we next tested whether (1) forced activation of Wnt/b-catenin
signaling inMaSC/basal cells also suppresses their luminal/alve-
olar differentiation or Notch signaling; and (2) if so, whether these
inhibitory effects depend on Pygo2.
Application of 6-bromoindirubin-30-oxime (BIO), a GSK3 inhib-
itor that activates Wnt/b-catenin signaling (Sato et al., 2004), to
control MaSC/basal cells resulted in elevated expression of
Wnt target Axin2 and more rapid colony growth (Figures 5A,
S4A, and S4B). However, there was a dramatic reduction of
acinar colonies in BIO-treated cultures; the colonies that were
produced were mostly solid, lacked branches, and were
composed of a K14+ outer layer and multiple layers of K8+ inner
cells (Figures 5A, 5B, and S4B). The extent of BIO-induced acinar
colony reduction was significantly compromised when Pygo2
was absent (Figure 5C). BIO also reduced the expression of
K19, Muc1, b-casein, and Stat5a in control MaSC/basal cells,
and the fold reduction was considerably smaller in SSKO
MaSC/basal cells (Figure 5D). Finally, lentiviral expression of
DN-b-catenin, a stabilized form of b-catenin mimicking activated
Wnt signaling (Gat et al., 1998), caused a less significant reduc-
tion in the formation of acinar colonies in SSKO than in control
MaSC/basal 3D Matrigel cultures (Figures 5E, S4C, and S4D).
These results suggest that Pygo2 is required for the maximal
inhibitory effect of Wnt/b-catenin signaling on luminal/alveolar
differentiation of MaSC/basal cells.
BIO exerted different effects on Notch genes in control MaSC/
basal 3D culture: it repressed the expression of Notch3 and, to a
less extent, Notch4, but not Notch1 and Notch2 (Figure 5F and
data not shown). Importantly, the repression of Notch3 did not
occur in Pygo2 SSKO MaSC/basal 3D culture (Figure 5F). Simi-
larly, BIO inhibited the expression of Hey1, and this effect was
partially reversed by loss of Pygo2 (Figure 5G). Thus, Pygo2 is
required for BIO inhibition of Notch3 expression and signaling.
In an interesting contrast, Axin2 expression in MaSC/basal 3D
cultures was reduced by Pygo2 loss regardless of BIO presence
(Figure S4A).Figure 4. Pygo2-Deficiency-Induced Luminal/Alveolar Differentiation o
(A) RT-qPCR analysis of Notch pathway gene expression in sorted populations f
(B) Representative FACS profiles of surface Notch3 protein expression in control
the right (n = 3 per genotype).
(C) Morphology (left) and quantification (right) of colonies produced by DMSO- o
Ade-Cre-infected MaSC/basal cells from Pygo2flox/+ and Pygo2flox/flox mice (n =
(D) RT-qPCR analysis of colonies formed as in (C). n = 3 per genotype. Note tha
prominent after culturing MaSC/basal cells in Matrigel as the difference in freshl
(E) Quantification of colonies produced by MaSC/basal cells from control and SS
lentiviruses.
(F) Effect of Cbf1 knockdown onmammary outgrowths from control and Pygo2 SS
fluorescence (left), and branching frequency was calculated as the number of t
resolution fields from multiple transplants (n = 2–6 each) (right). Arrow indicates
**p < 0.01.
See also Figure S3.Pygo2 Recruits b-Catenin to, and Maintains a Bivalent
Domain at, the Notch3 Locus in MaSC/Basal Cells
To date, a few genes have been identified as being directly
repressed by Wnt/b-catenin signaling and none by Pygo2 (Hov-
erter and Waterman, 2008; Jessen et al., 2008). We therefore
determined whether Notch3 is a direct target of Pygo2 or b-cat-
enin. We performed micro chromatin immunoprecipitation
(microChIP) (Dahl and Collas, 2008) that allowed the determina-
tion of protein binding to chromatin using purified MaSC/basal
cells. With Pygo2 antibody and multiple primer sets spanning
a5 kb to +5 kb region relative to the putative Notch3 transcrip-
tional start site (TSS), we detected appreciable signals at three
sites: c and e upstream of TSS, and h within a putative
enhancer/repressor at +5 kb (http://genome.ucsc.edu/
ENCODE/) (Figures 6A and 6B). ChIP signals were significantly
reduced in Pygo2 SSKOMaSC/basal cells, demonstrating spec-
ificity. Interestingly, the strongest binding site, h, does not
contain known lymphoid enhancer factor/T cell factor (LEF/
TCF) consensus sequence, whereas several putative LEF/TCF
sites (e.g., a, b, and d) did not exhibit Pygo2 occupancy. Thus,
a LEF/TCF consensus sequence is not essential for Pygo2
occupancy.
b-catenin also bound to site e, but not to c and h (Figure 6B).
Importantly, binding to e was markedly reduced in Pygo2
SSKO MaSC/basal cells, suggesting that Pygo2 is required for
recruiting b-catenin and/or stabilizing its binding to the Notch3
promoter. This dependence was surprising, given the proposed
model that Pygopus proteins are recruited to chromatin by amo-
lecular chain composed of LEF/TCF, b-catenin, and adaptor
Lgs/Bcl9 (Sta¨deli and Basler, 2005). To ask whether this finding
is applicable to other Wnt targets, we examined Pygo2 and
b-catenin binding to the Axin2 locus. In MaSC/basal cells, both
Pygo2 and b-catenin bound to site a, which is near the TSS
and contains a LEF/TCF consensus motif, but not site b, which
lies downstream (Jho et al., 2002) (Figures 6C and 6D). Impor-
tantly, binding of both proteins was reduced to a background
level when Pygo2 was absent.
Given the known involvement of Pygo2 in histone modifica-
tion, we examined H3K4me3 as well as two repressive histone
marks, trimethylated lysine 27 of histone H3 (H3K27me3) and
trimethylated lysine 9 of histone H3 (H3K9me3), at the Notch3
locus in control and Pygo2-deficient cells. In control MaSC/
basal cells, both H3K4me3 and H3K27me3 were found across
the Notch3 locus, with extensive low-level peaks particularlyf MaSC/Basal Cells Requires Notch Signaling
rom control and Pygo2 SSKO mice (n = 2 each).
and SSKO MaSC/basal cells. The Notch3high subpopulation was quantified on
r DAPT-treated MaSC/basal cells from control and SSKO mice (n = 3 each), or
4 each). Bar = 300 mm.
t the difference in K19 expression caused by Pygo2 deficiency is no longer as
y sorted cells.
KO mice (n = 3 each) with infection of control scramble shRNA or Cbf1 shRNA
KOMaSC/basal cells transplanted in vivo. Transplants were visualized by GFP
otal branching points per total ductal length (mm) in randomly selected high-
colonized GFP+ cells with no outgrowth. Values are means ± SD. *p < 0.05;
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Figure 5. Pygo2-Dependent Wnt/b-Catenin Suppression of Induced Luminal/Alveolar Differentiation and Notch3 Expression in MaSC/Basal
Cells
(A) Quantification of the size (left) and type (right) of colonies derived fromBIO (0.5 mM)-treatedMaSC/basal cells. Percent of acinar-like colonies per total colonies
was calculated for cultures 1 and 5 days after HIP induction (mean ± SD; n = 2mice). (B) Immunofluorescent detection of K8 (red) and K14 (green)-positive cells in
colonies produced by DMSO- or BIO-treatedMaSC/basal cells. Arrow, solid colony; arrowhead, acinus. (C) Morphology (left) and quantification (right) of colonies
produced byDMSO- or BIO-treated control and SSKO (n = 3 each)MaSC/basal cells. (D, F, andG) RT-qPCR analysis of the indicated genes in colonies formed as
in (C). (E) Quantification of colonies produced by MaSC/basal cells from control and SSKO mice (n = 3 each) with infection of control GFP or GFP/DN-b-catenin
lentiviruses. Values are means ± SD. *p < 0.05; **p < 0.01. Bar = 50 mm in (B) and 300 mm in (C). See also Figure S4.
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Figure 6. Pygo2 Regulates b-Catenin Bind-
ing and Chromatin Configuration at the
Notch3 Locus
(A and C) Schematic diagrams showing themouse
Notch3 (A) and Axin2 (C) loci. Triangles, putative
LEF/TCF-binding sites; short lines, amplicons (a–h
forNotch3 and a and b forAxin2) in qPCR analysis.
(B and D–G) Results of microChIP-qPCR analysis
of Pygo2 and b-catenin binding (B and D) and
histone modifications (E–G) at the Notch3 (B, E,
and F) and Axin2 (D and G) genes. Shown in (B),
(D), (E), and (G) are average values from three pairs
of control and SSKO mice (±SD). *p < 0.05 (be-
tween control and SSKO). Shown in (F) are
average values from twoWTmice (±SD) atNotch3
amplicon e. All signals were acquired with removal
of IgG background first and then normalization to
inputs. Histone modification signals were further
normalized to histone H3.
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configuration is reminiscent of the ‘‘bivalent domain’’ found
at promoters of many developmental genes that need to
be silenced in embryonic stem cells (ESCs) but are poised
for prompt activation upon lineage differentiation (Bernstein
et al., 2006; Mikkelsen et al., 2007). A strong peak of
H3K9me3 was observed at site c (Figure 6E). In control bulk
luminal cells, site e displayed a high level of H3K4me3 and a
low level of H3K27me3 (Figure 6F). Thus, the Notch3 locus
appears to be in a poised but silenced state in MaSC/basal
cells and is resolved to an active chromatin configuration in
luminal cells. In contrast, the Axin2 locus is in a predominantly
active state in MaSC/basal cells, as evident by the strong
H3K4me3 but background-level H3K27me3 signals at sites a
and b (Figure 6G).Cell Stem Cell 13,In Pygo2 SSKO MaSC/basal cells,
there was a general increase in
H3K4me3 across the Notch3 locus, with
the normally broad but weak H3K4me3
signals between TSS and the down-
stream enhancer now being replaced by
prominent peaks centered around f (Fig-
ure 6E). In contrast, both H3K27me3
and H3K9me3 levels were decreased,
especially at the proximal gene regulatory
region (Figure 6E). Thus, it appears that
with Pygo2 loss, the bivalent domain at
the Notch3 locus in MaSC/basal cells
was resolved to an active chromatin
configuration, reminiscent of that in
normal luminal cells. This is in contrast
to the Axin2 locus, where Pygo2 loss re-
sulted in a significant reduction in
H3K4me3 at site a (to which both Pygo2
and b-catenin bind, but not site b; Fig-
ure 6G). Collectively, our data suggest
that Pygo2 functions in MaSC/basal cells
to maintain the Notch3 locus in a bivalent
chromatin state to prevent it from beingprematurely resolved to an active state compatible with luminal
differentiation.
DISCUSSION
Our study identifies Pygo2 as an epigenetic gatekeeper of the
MaSC/basal fate and adds Pygo2 to a small list of known chro-
matin regulators of mammary epithelial stem/progenitor cells (Liu
et al., 2006; Pal et al., 2013; Pietersen et al., 2008). That Pygo2 is
expressed, and suppresses the luminal-like gene signature, in
MaSC/basal cells provides at least one epigenetic mechanism
bywhich these cellsmaintain their lineage identity during develop-
ment (van Amerongen et al., 2012; VanKeymeulen et al., 2011). To
our knowledge, this is the first study to show that a histonemethyl-
ation reader (i.e., Pygo2) regulates the lineage potential of adult48–61, July 3, 2013 ª2013 Elsevier Inc. 57
Figure 7. Working Model on Pygo2 Regulation of Mammary Epithe-
lial Lineage Differentiation
Pygo2 binding facilitates the binding of b-catenin and a bivalent chromatin
configuration at the Notch3 locus in MaSC/basal cells. In Pygo2 null MaSC/
basal cells, Notch3 chromatin shifts precociously from having dominant
repressive H3K27me3 marks to prominent permissive H3K4me3 marks,
allowing derepression/activation of Notch3. See text for details.
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Pygo2 in Breast Stem Cell Differentiationepithelial stem cells. With the recent success in identifying small-
molecule inhibitors that block the activities of histone readers
(Chung, 2012), understanding the biological function of this class
of chromatin effectors opens newdoors todirect the lineagediffer-
entiationpotential of stemcells for tissueengineeringand treathet-
erogeneous human cancers with a stem/progenitor cell origin. In
fact, we observed that Pygo2 loss leads to a restriction of the line-
agepotential of tumor-initiatingcells in theMMTV-Wnt1mammary
tumor model (Watanabe et al., 2013).
Our discovery of the Pygo2-deficiency-induced partial drift of
MaSC/basal gene expression toward a mature luminal state is
particularly interesting, as a dramatic differentiation phenotype
of these Pygo2-deficient MaSC/basal cells is only manifest
upon switching to lactogenic conditions that induce luminal/
alveolar differentiation. This presents a previously unrecognized
mode of molecular regulation, namely ‘‘prospective’’ regulation,
of mammary stem/progenitor cells, where a chromatin effector
earmarks their differentiation competence. It is important to
note that the LinCD29highCD24+ MaSC/basal population is
inherently heterogeneous in its cellular constituents. Our
detection of two distinct subpopulations of Notch3-expressing
cells within this population is consistent with the reported
finding of low and high expression of Hey1 in Axin2+ and
Axin2, respectively, fractions of the LinCD29highCD24+ pool
(Zeng and Nusse, 2010). Interestingly, Pygo2 loss results in a
general upward shift in Notch3 expression of the entire
MaSC/basal population while maintaining two distinct subpop-
ulations. As the Wnt-responsive Axin2+ cells are further en-
riched for MaSC cells, our findings are consistent with Pygo2
repressing Notch3 expression in not only MaSCs, but also
bulk basal cells.
Our study provides evidence for a functional and mechanistic
connection between two fundamentally important signaling
pathways, Wnt and Notch, in negotiating the choice between
MaSC/basal and luminal lineages within the mammary epithelia.
Specifically, our findings highlight Pygo2 as an epigenetic pro-
ponent of the self-renewal/basal-promoting Wnt/b-catenin
signaling and a direct epigenetic suppressor of the luminal-pro-
moting Notch signaling. Because these two pathways regulate
the fates of stem cells in myriad tissues and in tumors, our study
adds to the general knowledge of how developmental signaling
pathways crosstalk with each other (Shahi et al., 2011). Of
note, the negative regulation of Notch3 by Wnt signaling and
Pygo2 (this study) contrasts the activation of Notch2 by Wnt
signaling in colorectal cancer cells, underscoring the cell/tis-
sue-type specificity of Wnt-Notch crosstalks (Duncan et al.,
2005; Ungerba¨ck et al., 2011).
Our work identifies Notch3 as a direct target of transcriptional
repression by Wnt/b-catenin and Pygo2, and as such also as-
signs an additional repressive role for Pygo2 in gene expression.
Intriguingly, Pygo2 is required for b-catenin binding to bothAxin2
and Notch3 gene regulatory regions. While this may be in
apparent conflict with the LEF/TCF-b-catenin-Lgs/Bcl9-Pygo
chain-of-adaptor model, it supports and refines an alternative
model wherein Pygo2 facilitates b-catenin nuclear retention (Sta¨-
deli and Basler, 2005; Townsley et al., 2004). Reconciling our
data with both models, Pygo2 and b-catenin may stabilize
each other’s occupancy at target loci via multivalent interactions
between Pygo2 and chromatin via H3K4me3, b-catenin and58 Cell Stem Cell 13, 48–61, July 3, 2013 ª2013 Elsevier Inc.LEF/TCF sites via LEF/TCF, and Pygo2 and b-catenin via Lgs/
Bcl9 (Gu et al., 2009). Overall, the functional interplay between
Wnt/b-catenin signaling and Pygo2 in MaSC/basal cells appears
complex: Pygo2 facilitates Wnt-induced alteration in some
genes (e.g., Notch3), but activates or represses other genes
(e.g., Axin2 and Notch1/2) regardless of the Wnt activation sta-
tus. This new mechanistic insight is entirely consistent with the
finding of both Wnt-dependent and Wnt-independent biological
functions of Pygopus proteins (Jessen et al., 2008).
Our work offers an additional example of how a histone code
reader can generate different chromatin and transcriptional out-
comes at different target loci. Specifically, Pygo2 is required for
optimal H3K4me3 at the Axin2 promoter but maintains a biva-
lent chromatin configuration at a key lineage-regulatory locus,
Notch3, in MaSC/basal cells. Bivalent domains have been
found in not only ESCs but also adult cells, including the
mammary epithelial lineage (Cui et al., 2009; Lien et al., 2011;
Maruyama et al., 2011; Pal et al., 2013); however, their func-
tional significance remains to be fully characterized. Our dis-
covery that loss of a bivalent status at the Notch3 locus
correlates with altered lineage potential provides important
though indirect evidence for the significance of a bivalent chro-
matin configuration. We postulate that in normal MaSC/basal
cells, Pygo2 helps to maintain the Notch3 locus in a poised
yet repressed state to ensure a low level of Notch3 expression
(Raafat et al., 2011) and prevent the cells from prematurely
adopting a luminal/alveolar fate (Figure 7, left). When Pygo2 is
absent, the Notch3 chromatin undergoes premature resolution
toward an active and luminal-like state to support gene expres-
sion, which in turn primes MaSC/basal cells for luminal/alveolar
differentiation upon extrinsic differentiation cues (Figure 7,
right). Future studies will investigate the molecular mechanism
by which Pygo2 regulates histone modifications at the Notch3
locus.
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Mouse Strains
Pygo2 SSKO female mice were generated in congenic C57BL/6 background
from a crossing of K14-cre; Pygo2+/males with Pygo2flox/flox females as pre-
viously described (Gu et al., 2009). Pygo2flox/flox and Pygo2flox/+ female litter-
mates were generated from a crossing of Pygo2flox/+ males with Pygo2flox/flox
females.
Flow Cytometry, Sorting, and 3D Matrigel Differentiation Assay
Mammary cells from 8- to 12-week-old virgin females were immunolabeled
with specific antibodies (CD31-APC, CD45-APC, TER119-APC, CD24-PE-
Cy7, CD29-FTIC, CD49f-FITC, CD61-PE, or Notch3-PE) and analyzed by
LSRII (BD Biosciences) or sorted by FACSAriaII (BD Biosciences). Data anal-
ysis was performed by Flowjo 7.6.1.
3D Matrigel assay was performed as previously reported (Shackleton et al.,
2006). Briefly, sorted MaSC/basal cells were resuspended in growth factor
reduced Matrigel (BD Biosciences) and plated onto 8-well chamber slides
(Thermo Fisher Scientific). Cells were cultured in a mammary epithelial growth
medium for 1 week and induced to undergo luminal/alveolar differentiation by
medium switch to DMEM/F12 containing hydrocortisone, insulin, and prolactin
(HIP) and 1% FBS.
To acutely delete Pygo2, sorted Pygo2flox/flox and control Pygo2flox/+MaSC/
basal cells were infected in suspension with Ade-Cre (Vector Biolabs) before
being embedded in Matrigel. To modulate signaling pathways, growing
cells/colonies were pretreated with DMSO, DAPT (Calbiochem), or BIO
(Sigma-Aldrich) for 24 hr in growth medium before being switched to differen-
tiation medium (referred to as Day 0) containing the same agent.
Cleared Fat Pad Transplantation
FACS-sorted MaSC/basal cells were injected into the cleared fat pad of
3-week-old female C57BL/6 mice. Cbf1 knockdown was performed by
transduction with shCbf1-expressing lentiviruses before transplantation. Out-
growths were analyzed 8 weeks after transplantation. GFP fluorescence was
visualized with a Leica MZFLIII dissecting scope or Nikon E600 microscope.
Statistical analysis of the take rate was performed using the ELDAWeb-based
tool (http://bioinf.wehi.edu.au/software/elda/), and the statistical difference in
filled fat pad area was estimated by one-way ANOVA.
MicroChIP
MicroChIP was performed according to the protocol described previously
(Dahl and Collas, 2008) using 5 3 104 sorted cells. The primers for qPCR are
summarized in Table S2.
Additional details for the above procedures, as well as procedures for lenti-
viral expression/shRNA, western blot, RNA isolation, RT-qPCR, indirect immu-
nofluorescence, whole-mount staining, and microarray analysis (GSE45826),
are described in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes Supplemental Experimental
Procedures and four figures and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2013.04.012.
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